Natera (NTRA) Stock Forecast & Price Target

Compare

1,156 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

NTRA Analyst Ratings

Strong Buy

15 Buy

1 Hold

0 Sell

Based on 16 analysts giving stock ratings to

Natera

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

NTRA Stock 12 Month Forecast

Average Price Target

$258.27

▲(9.47% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $258.27 with a high forecast of $300.00 and a low forecast of $205.00. The average price target represents a 9.47% change from the last price of $235.93.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"133":"$133","175":"$175","217":"$217","259":"$259","301":"$301"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$300.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":258.26666666666665,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$258.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":205,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$205.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[133,175,217,259,301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,229.09,234.54461538461538,239.99923076923076,245.45384615384614,250.90846153846155,256.3630769230769,261.8176923076923,267.27230769230766,272.7269230769231,278.1815384615385,283.63615384615383,289.09076923076924,294.5453846153846,{"y":300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,229.09,231.33435897435896,233.57871794871795,235.8230769230769,238.0674358974359,240.31179487179486,242.55615384615385,244.8005128205128,247.0448717948718,249.28923076923076,251.53358974358974,253.7779487179487,256.02230769230766,{"y":258.26666666666665,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,229.09,227.2369230769231,225.38384615384615,223.53076923076924,221.6776923076923,219.82461538461538,217.97153846153847,216.11846153846153,214.26538461538462,212.4123076923077,210.55923076923077,208.70615384615385,206.8530769230769,{"y":205,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":158.3,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.92,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.65,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.36,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.58,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":161.61,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.93,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234.25,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":229.09,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$300.00

Average Price Target$258.27

Lowest Price Target$205.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Luke Sergott

Barclays

$270

Buy

14.44%

Upside

Reiterated

01/22/26

Analysts' Top Healthcare Picks: Natera (NTRA), Corcept Therapeutics (CORT)

David Westenberg

Piper Sandler

$230

Buy

-2.51%

Downside

Reiterated

01/14/26

Piper Sandler Reaffirms Their Buy Rating on Natera (NTRA)

Kallum Titchmarsh

Morgan Stanley

$265

Buy

12.32%

Upside

Reiterated

01/12/26

Natera: Accelerating MRD Momentum, Revenue Outperformance, and Improving Cash Profile Support Buy Rating

Kyle Mikson CFA

Canaccord Genuity

$285

Buy

20.80%

Upside

Reiterated

01/12/26

We reiterate our Buy rating on Natera (NTRA) shares and maintain our price target at $285.

Daniel Brennan

TD Cowen

$240→$280

Buy

18.68%

Upside

Reiterated

01/07/26

Natera price target raised to $280 from $240 at TD CowenNatera price target raised to $280 from $240 at TD Cowen

Patrick B Donnelly

Citi

$300

Buy

27.16%

Upside

Initiated

01/07/26

Natera: Leading MRD Position, Expanding Margins, and Premium Valuation Support Buy Rating and $300 Target

Subbu Nambi

Guggenheim

$270

Buy

14.44%

Upside

Reiterated

01/02/26

Guggenheim Sticks to Their Buy Rating for Natera (NTRA)

Tycho Peterson

Jefferies

$230→$275

Buy

16.56%

Upside

Reiterated

12/17/25

Jefferies Reaffirms Their Buy Rating on Natera (NTRA)

Richard Shannon

Craig-Hallum

Buy

―

Reiterated

12/16/25

Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Natera (NTRA)

Brandon Couillard

Wells Fargo

$190→$205

Hold

-13.11%

Downside

Reiterated

12/15/25

Natera price target raised to $205 from $190 at Wells FargoNatera price target raised to $205 from $190 at Wells Fargo

Casey Woodring

J.P. Morgan

$250→$260

Buy

10.20%

Upside

Reiterated

12/15/25

Natera price target raised to $260 from $250 at JPMorganNatera price target raised to $260 from $250 at JPMorgan

Dan Leonard

UBS

$218→$280

Buy

18.68%

Upside

Reiterated

11/18/25

Natera price target raised to $280 from $218 at UBSNatera price target raised to $280 from $218 at UBS

Unknown Analyst

Stephens

Not Ranked

Stephens

$209.5→$235

Buy

-0.39%

Downside

Reiterated

11/13/25

Stephens Reaffirms Their Buy Rating on Natera (NTRA)

Catherine Ramsey Schulte

Robert W. Baird

$200→$239

Buy

1.30%

Upside

Reiterated

11/07/25

Natera price target raised to $239 from $200 at BairdNatera price target raised to $239 from $200 at Baird

Daniel Markowitz CFA

Evercore ISI

$190→$250

Buy

5.96%

Upside

Reiterated

11/07/25

Natera price target raised to $250 from $190 at Evercore ISINatera price target raised to $250 from $190 at Evercore ISI

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Luke Sergott

Barclays

$270

Buy

14.44%

Upside

Reiterated

01/22/26

Analysts' Top Healthcare Picks: Natera (NTRA), Corcept Therapeutics (CORT)

David Westenberg

Piper Sandler

$230

Buy

-2.51%

Downside

Reiterated

01/14/26

Piper Sandler Reaffirms Their Buy Rating on Natera (NTRA)

Kallum Titchmarsh

Morgan Stanley

$265

Buy

12.32%

Upside

Reiterated

01/12/26

Natera: Accelerating MRD Momentum, Revenue Outperformance, and Improving Cash Profile Support Buy Rating

Kyle Mikson CFA

Canaccord Genuity

$285

Buy

20.80%

Upside

Reiterated

01/12/26

We reiterate our Buy rating on Natera (NTRA) shares and maintain our price target at $285.

Daniel Brennan

TD Cowen

$240→$280

Buy

18.68%

Upside

Reiterated

01/07/26

Natera price target raised to $280 from $240 at TD CowenNatera price target raised to $280 from $240 at TD Cowen

Patrick B Donnelly

Citi

$300

Buy

27.16%

Upside

Initiated

01/07/26

Natera: Leading MRD Position, Expanding Margins, and Premium Valuation Support Buy Rating and $300 Target

Subbu Nambi

Guggenheim

$270

Buy

14.44%

Upside

Reiterated

01/02/26

Guggenheim Sticks to Their Buy Rating for Natera (NTRA)

Tycho Peterson

Jefferies

$230→$275

Buy

16.56%

Upside

Reiterated

12/17/25

Jefferies Reaffirms Their Buy Rating on Natera (NTRA)

Richard Shannon

Craig-Hallum

Buy

―

Reiterated

12/16/25

Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Natera (NTRA)

Brandon Couillard

Wells Fargo

$190→$205

Hold

-13.11%

Downside

Reiterated

12/15/25

Natera price target raised to $205 from $190 at Wells FargoNatera price target raised to $205 from $190 at Wells Fargo

Casey Woodring

J.P. Morgan

$250→$260

Buy

10.20%

Upside

Reiterated

12/15/25

Natera price target raised to $260 from $250 at JPMorganNatera price target raised to $260 from $250 at JPMorgan

Dan Leonard

UBS

$218→$280

Buy

18.68%

Upside

Reiterated

11/18/25

Natera price target raised to $280 from $218 at UBSNatera price target raised to $280 from $218 at UBS

Unknown Analyst

Stephens

Not Ranked

Stephens

$209.5→$235

Buy

-0.39%

Downside

Reiterated

11/13/25

Stephens Reaffirms Their Buy Rating on Natera (NTRA)

Catherine Ramsey Schulte

Robert W. Baird

$200→$239

Buy

1.30%

Upside

Reiterated

11/07/25

Natera price target raised to $239 from $200 at BairdNatera price target raised to $239 from $200 at Baird

Daniel Markowitz CFA

Evercore ISI

$190→$250

Buy

5.96%

Upside

Reiterated

11/07/25

Natera price target raised to $250 from $190 at Evercore ISINatera price target raised to $250 from $190 at Evercore ISI

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Natera

3 Months

xxx

Success Rate

27/38 ratings generated profit

Average Return

+14.04%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.05% of your transactions generating a profit, with an average return of +14.04% per trade.

1 Year

Daniel BrennanTD Cowen

Success Rate

15/17 ratings generated profit

Average Return

+60.05%

reiterated a buy rating 24 days ago

Copying Daniel Brennan's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +60.05% per trade.

2 Years

xxx

Success Rate

31/33 ratings generated profit

Average Return

+146.69%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 93.94% of your transactions generating a profit, with an average return of +146.69% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NTRA Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, NTRA has received 34 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NTRA average Analyst price target in the past 3 months is 258.27.

Each month's total comprises the sum of three months' worth of ratings.

NTRA Financial Forecast

NTRA Earnings Forecast

Next quarter’s earnings estimate for NTRA is -$0.51 with a range of -$0.93 to -$0.17. The previous quarter’s EPS was -$0.64. NTRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.25% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Sales Forecast

Next quarter’s sales forecast for NTRA is $604.04M with a range of $564.96M to $660.45M. The previous quarter’s sales results were $592.18M. NTRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.18% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Stock Forecast FAQ

What is NTRA’s average 12-month price target, according to analysts?

Based on analyst ratings, Natera’s 12-month average price target is 258.27.

What is NTRA’s upside potential, based on the analysts’ average price target?

Natera has 9.47% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is NTRA a Buy, Sell or Hold?

Natera has a consensus rating of Strong Buy which is based on 15 buy ratings, 1 hold ratings and 0 sell ratings.

What is Natera’s price target?

The average price target for Natera is 258.27. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $300.00 ,the lowest forecast is $205.00. The average price target represents 9.47% Increase from the current price of $235.93.

What do analysts say about Natera?

Natera’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of NTRA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Natera (NTRA) Stock Forecast & Price Target

NTRA Analyst Ratings

NTRA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Natera

NTRA Analyst Recommendation Trends

NTRA Financial Forecast

NTRA Earnings Forecast

NTRA Sales Forecast

NTRA Stock Forecast FAQ

Detailed List of Analyst Forecasts